Search

Your search keyword '"Mirela Cerghet"' showing total 19 results

Search Constraints

Start Over You searched for: Author "Mirela Cerghet" Remove constraint Author: "Mirela Cerghet" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
19 results on '"Mirela Cerghet"'

Search Results

1. Current understanding of cardiovascular autonomic dysfunction in multiple sclerosis

2. Utility of an Untargeted Metabolomics Approach Using a 2D GC-GC-MS Platform to Distinguish Relapsing and Progressive Multiple Sclerosis

3. Multi-omic evaluation of metabolic alterations in multiple sclerosis identifies shifts in aromatic amino acid metabolism

4. Tales of a department: how the COVID-19 pandemic transformed Detroit’s Henry Ford Hospital, Department of Neurology—part I: the surge

5. Blood-based untargeted metabolomics in relapsing-remitting multiple sclerosis revealed the testable therapeutic target

6. Ofatumumab versus Teriflunomide in Multiple Sclerosis

7. Clinical and diagnostic spectrum of optic neuritis: A single-center retrospective study of disorders associated with multiple sclerosis, anti-aquaporin-4 and anti-myelin oligodendrocyte glycoprotein antibodies

8. Blood-based untargeted metabolomics in Relapsing-Remitting Multiple Sclerosis revealed the testable therapeutic target

9. Review of the COVID-19 Risk in Multiple Sclerosis

10. COVID-19 and Autoimmune Demyelinating Diseases

11. Neuropathogenesis of SARS-CoV-2 Infection

12. Contributors

13. COVID-19 in multiple sclerosis patients and risk factors for severe infection

14. COVID-19 in Multiple Sclerosis Patients and Risk Factors for Severe Infection

15. The effect of race on clinical presentation and outcomes in neurosarcoidosis

16. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis

17. Blood-based untargeted metabolomics in Relapsing-Remitting Multiple Sclerosis revealed testable therapeutic target

18. Resting state fMRI connectivity analysis as a tool for detection of abnormalities in five different cognitive networks of the brain in MS patients

19. Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis*

Catalog

Books, media, physical & digital resources